April 25th, 2022, the U.S. Food and Drug Administration expanded the approval of the COVID-19 treatment Veklury (remdesivir) to include pediatric patients 28 days of age and older weighing at least 3 kilograms (about 7 pounds) with positive results of direct SARS-CoV-2 viral testing, who are hospitalized, ornot hospitalized and have mild-to-moderate COVID-19 and are…
Read MoreRecent Posts
- My partner and I got COVID-19 vaccines while I was pregnant, but is it safe for our newborn to be around unvaccinated people?
- Pfizer announces positive findings from COVID vaccine booster for ages 5-11
- Coronavirus (COVID-19) Update: FDA Approves First COVID-19 Treatment for Young Children
- COVID-19 Vaccine Checklist for Kids Age 5 and Up
- Starting Solid Foods